Search Orphan Drug Designations and Approvals
-
| Generic Name: | afatinib |
|---|---|
| Date Designated: | 06/04/2014 |
| Orphan Designation: | Treatment of malignant brain and central nervous system tumors |
| Orphan Designation Status: | Designated/Withdrawn |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road P. O. Box 368 Ridgefield, Connecticut 06877 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
